PHARMAKON ADVISORS
Pharmakon Advisors is a New York-based investment company that offers financing solutions to commercial stage, biotechnology companies.
PHARMAKON ADVISORS
Status:
Active
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-08 | UroGen Pharma | Pharmakon Advisors investment in Post-IPO Debt - UroGen Pharma | 100 M USD |
| 2022-01-07 | Coherus Biosciences | Pharmakon Advisors investment in Post-IPO Debt - Coherus Biosciences | 100 M USD |
| 2021-12-14 | Evolus | Pharmakon Advisors investment in Post-IPO Debt - Evolus | 125 M USD |
| 2020-12-08 | BRAINBox Solutions | Pharmakon Advisors investment in Series A - BRAINBox Solutions | 23 M USD |
| 2020-09-12 | OptiNose | Pharmakon Advisors investment in Post-IPO Debt - OptiNose | 150 M USD |
| 2019-12-13 | Sarepta Therapeutics | Pharmakon Advisors investment in Post-IPO Debt - Sarepta Therapeutics | 250 M USD |
| 2019-11-12 | Akebia Therapeutics | Pharmakon Advisors investment in Post-IPO Debt - Akebia Therapeutics | 100 M USD |
| 2016-01-05 | Halozyme Therapeutics | Pharmakon Advisors investment in Post-IPO Debt - Halozyme Therapeutics | 150 M USD |
| 2015-03-13 | Assertio | Pharmakon Advisors investment in Post-IPO Debt - Assertio | 575 M USD |
| 2014-07-28 | PaxVax | Pharmakon Advisors investment in Debt Financing - PaxVax | 50 M USD |
More informations about "Pharmakon Advisors"
Home - Pharmakon Advisors, LP
Pharmakon Advisors, LP is an investment management firm specializing in providing strategic financing solutions to the life sciences industry. Pharmakon Advisors, LP, the investment …See details»
Pharmakon Advisors, LP - LinkedIn
Pharmakon Advisors, LP is the investment manager of the BioPharma Credit funds. Established in 2009, Pharmakon has raised a total of US$4.2 billion, principally across five private funds …See details»
Pharmakon Advisors - Contacts, Employees, Board Members, …
Pharmakon Advisors is a New York-based investment company that offers financing solutions to commercial stage, biotechnology companies.See details»
Pharmakon Advisors - Fund and Executive Details
Pharmakon Advisors is a private equity company based in New York, NY. They operate 3 private funds and have approximately $1.05 billion in total assets under management (AUM). You can …See details»
Pharmakon Advisors, LP Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Pharmakon Advisors, LP of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Pharmakon Advisors - Tech Company Lender Profile - gaebler.com
Pharmakon Advisors is a lender that provides debt as part of tech company funding rounds.See details»
PHARMAKON ADVISORS, LP | Form ADV - Radient
PHARMAKON ADVISORS, LP is an investment services firm founded in 2009, specializing in investment management for private funds and providing advisory services to a public limited …See details»
Pharmakon Advisors - Investor Profile, Portfolio & Team - Tracxn
Jan 29, 2025 Pharmakon Advisors, established in 2009, is a private debt fund primarily based in New York City, United States. It specializes in financing Post IPO and Series A round s of …See details»
Pharmakon Advisors Company Profile | Management and
Find contact information for Pharmakon Advisors. Learn about their Finance market share, competitors, and Pharmakon Advisors's email format.See details»
Pharmakon Advisors Portfolio Investments, Pharmakon Advisors …
About Pharmakon Advisors Investment funds managed by Pharmakon Advisors have raised over $1 billion to provide financing to commercial stage companies in the biotech, specialty pharma, …See details»
Pharmakon Advisors Company Profile: Financings & Team
General Information Description Established in 2009, Pharmakon Advisors is a lender based in New York City, New York. The firm provides debt financing facilities such as loans for initial …See details»
Pharmakon Advisors, LP Company Overview, Contact Details
Learn more about Pharmakon Advisors, LP's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Pharmakon Advisors - Private Equity International
Pharmakon Advisors News, insights, analysis and data Pharmakon Advisors overview Founded in 2009, Pharmakon Advisors is a New York-based investment firm targeting debt investments in …See details»
Pharmakon Advisors LP - Company Profile and News
Pharmakon Advisors, LP provides investment advisory services. The Company offers investment management, financial planning, and consulting services.See details»
Pharmakon Advisors, Lp - SmartAdvisor Match
Pharmakon Advisors, Lp is located at 110 East 59th Street, New York, NY. The firm employs 7 financial advisors to manage client portfolios and provide financial guidance. Pharmakon …See details»
Pharmakon Advisors LP Company Profile, Financial and ... - digitGaps
DigitGaps report on Pharmakon Advisors LP delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and …See details»
Pharmakon Advisors - Fundopedia
Pharmakon Advisors is the investment manager of the BioPharma Credit funds, specializing in life sciences debt investments. Established in 2009, the firm has raised a total of US$4.9 billion …See details»
Pharmakon Advisors, Lp in New York, NY - U.S. News
For more detailed information on Pharmakon Advisors, Lp ’s conduct, please visit Finra’s BrokerCheck, the SEC’s Investment Adviser Public Disclosure database, or your state’s …See details»
BioCryst Refinances Existing Debt with $450 Million Financing ...
Apr 18, 2023 Pharmakon Advisors, LP is a leading investor in non-dilutive debt for the life sciences industry and is the investment manager of the BioPharma Credit funds. Established …See details»
Advising Pharmakon in its $646 million secured financing
Sep 5, 2024 Pharmakon Advisors, LP and its affiliated funds provided Collegium Pharmaceutical with a $646 million secured financing to be used to help fund Collegium’s acquisition of …See details»